Literature DB >> 30375932

Quantitative Assessment of Liver Function by Using Gadoxetic Acid-enhanced MRI: Hepatocyte Uptake Ratio.

Jeong Hee Yoon1, Jeong Min Lee1, Hyo-Jin Kang1, Su Joa Ahn1, Hyunkyung Yang1, Eunju Kim1, Tomoyuki Okuaki1, Joon Koo Han1.   

Abstract

Purpose To determine whether hepatocyte uptake ratios derived at gadoxetic acid-enhanced MRI correlate with quantitative measures of liver function and can help to identify contraindication to major hepatectomy. Materials and Methods Between August 2016 and October 2016, 50 study participants with chronic liver disease or cirrhosis underwent liver MRI at 3.0 T including T1 mapping and elastography. Liver function was quantitatively assessed by using the indocyanine green retention test (ICG R15). T1 maps were obtained by using the Look-Locker sequence before and 10 minutes after gadoxetic acid administration (0.025 mmol/kg). The relationship between ICG R15 and the following MRI parameters was evaluated: pre- and postcontrast T1 values of the liver, hepatocyte uptake ratio representing the amount of contrast media solely taken into hepatocytes, liver volume, and degree of enhancement at the common bile duct. Diagnostic performance of the hepatocyte uptake ratio to identify patients with ICG R15 greater than 20% (ie, contraindication to hepatectomy) was compared with other parameters by using areas under the receiver operating characteristic curve. Results Hepatocyte uptake ratio showed a negative correlation with ICG R15 r of -0.78 (P < .001). In participants with chronic liver disease or Child-Pugh class A, those with ICG R15 of 20% or less showed higher hepatocyte uptake ratio than those with ICG R15 greater than 20% (P < .001). Hepatocyte uptake ratios demonstrated better performance for helping to detect ICG R15 greater than 20% than did liver volume (area under the curve, 0.96 vs 0.70; P = .01). Conclusion Hepatocyte uptake ratios are negatively correlated with liver function as measured by indocyanine green retention test and provide acceptable diagnostic performance for helping to identify participants who have contraindications to major hepatectomy. © RSNA, 2018 Online supplemental material is available for this article. See also the editorial by Reeder in this issue.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30375932     DOI: 10.1148/radiol.2018180753

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  26 in total

Review 1.  Advances in functional and molecular MRI technologies in chronic liver diseases.

Authors:  Iris Y Zhou; Onofrio A Catalano; Peter Caravan
Journal:  J Hepatol       Date:  2020-06-22       Impact factor: 25.083

2.  Advanced liver imaging using MR to predict outcomes in chronic liver disease: a shift from morphology to function liver assessment.

Authors:  Francesco Verde; Valeria Romeo; Simone Maurea
Journal:  Quant Imaging Med Surg       Date:  2020-03

Review 3.  CT and MR perfusion techniques to assess diffuse liver disease.

Authors:  Maxime Ronot; Benjamin Leporq; Bernard E Van Beers; Valérie Vilgrain
Journal:  Abdom Radiol (NY)       Date:  2020-11

Review 4.  Patterns of enhancement in the hepatobiliary phase of gadoxetic acid-enhanced MRI.

Authors:  Cathryn L Hui; Marcela Mautone
Journal:  Br J Radiol       Date:  2020-06-01       Impact factor: 3.039

5.  Regional liver function analysis with gadoxetic acid-enhanced MRI and virtual hepatectomy: prediction of postoperative short-term outcomes for HCC.

Authors:  Mengqi Huang; Shunli Shen; Huasong Cai; Zhenpeng Peng; Wan Hang Keith Chiu; Zi-Ping Li; Baogang Peng; Shi-Ting Feng
Journal:  Eur Radiol       Date:  2021-01-15       Impact factor: 5.315

Review 6.  Intravenous gadolinium-based hepatocyte-specific contrast agents (HSCAs) for contrast-enhanced liver magnetic resonance imaging in pediatric patients: what the radiologist should know.

Authors:  Rama S Ayyala; Sudha A Anupindi; Michael S Gee; Andrew T Trout; Michael J Callahan
Journal:  Pediatr Radiol       Date:  2019-07-26

7.  GAN and dual-input two-compartment model-based training of a neural network for robust quantification of contrast uptake rate in gadoxetic acid-enhanced MRI.

Authors:  Josiah Simeth; Yue Cao
Journal:  Med Phys       Date:  2020-02-19       Impact factor: 4.071

8.  Performance of gadoxetic acid MRI and diffusion-weighted imaging for the diagnosis of early recurrence of hepatocellular carcinoma.

Authors:  Jordi Rimola; Alejandro Forner; Víctor Sapena; Neus Llarch; Anna Darnell; Alba Díaz; Angeles García-Criado; Lluís Bianchi; Ramon Vilana; Álvaro Díaz-González; Carmen Ayuso; Jordi Bruix; María Reig
Journal:  Eur Radiol       Date:  2019-08-01       Impact factor: 5.315

9.  Prediction of overt hepatic encephalopathy after transjugular intrahepatic portosystemic shunt treatment: a cohort study.

Authors:  Yang Yang; Sirui Fu; Bin Cao; Kenan Hao; Yong Li; Jianwen Huang; Wenfeng Shi; Chongyang Duan; Xiao Bai; Kai Tang; Shirui Yang; Xiaofeng He; Ligong Lu
Journal:  Hepatol Int       Date:  2021-05-11       Impact factor: 6.047

Review 10.  Noninvasive staging of liver fibrosis: review of current quantitative CT and MRI-based techniques.

Authors:  Won Hyeong Im; Ji Soo Song; Weon Jang
Journal:  Abdom Radiol (NY)       Date:  2021-07-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.